UniCredit Aktienanleihe OMV 28.03.../ DE000HD46P23 /
15/11/2024 19:34:25 | Var.-0.220 | Denaro21:59:00 | Lettera21:59:00 | Sottostante | Prezzo di esercizio | Expiration date | Tipo di opzione |
---|---|---|---|---|---|---|---|
99.920EUR | -0.22% | 99.010 Quantità in denaro: 60,000 |
101.570 Quantità in lettera: 60,000 |
OMV AG | 36.1077 EUR | 28/03/2025 | Call |
GlobeNewswire
26/03
Intravacc announces positive data of first in human intranasal OMV based vaccine for SARS-CoV-2
GlobeNewswire
16/01
Intravacc Awarded US$ 633K CARB-X Funding to Develop a Vaccine that Prevents Gonorrhea Infections
GlobeNewswire
14/09/2023
Intravacc Announces Review Publication of OMV-based Intranasal Vaccines for Disease Prevention
GlobeNewswire
04/12/2018
CGG and OMV: Continue Cooperation with Multi-Year Extension of Dedicated Center
GlobeNewswire
04/12/2018
CGG and OMV: Continue Cooperation with Multi-Year Extension of Dedicated Center